Investor
A study published in medRxiv reveals that inference techniques including chain-of-thought and search augmented generation can reduce AI hallucination rates.
Also, Heidi Health has announced a new partnership for its New Zealand expansion.
The funds will be used to advance Insilico's drug pipeline and lab, which automates the research and development process, and refine its AI-enabled models and algorithms.
The funds will be used to expand the U.S. and European reach of its FDA-cleared tinnitus treatment device, Lenire, including with the Department of Veterans Affairs.
The San Francisco-based digital musculoskeletal care company filed to go public on Monday and will list under the ticker symbol HNGE.
The MSK company will use the funds to expand its value-based care initiatives and advance its technology and clinical programs.
It is also expected to offer a new digital weight loss program.
The New York-based company also reported a 110% increase in fourth-quarter revenue in 2024 compared to Q4 2023 and a Q4 2024 net loss of $9.6 million.
Leaders of government public policy at HIMSS are prioritizing health equity, AI regulation, cybersecurity and workforce development while urging unified policies that support healthcare innovation.
Upcoming features include pre-chart summary creation.